Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Advances in Psoriasis
A Multisystemic Guide
Weinberg, Lebwohl,
Editore
Springer
Anno
2021
Pagine
423
ISBN
9783030548612
80,00 €
DA SCONTARE
This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease.
Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients.
-
Introduction to and History of Psoriasis and Psoriasis Therapy
Pages 1-7
Cameron, John B. (et al.)
-
Pathophysiology of Psoriasis/Novel Pathways
Pages 9-18
Hugh, Jeremy M. (et al.)
-
Psoriasis: Clinical Review and Update
Pages 19-25
Grozdev, Ivan (et al.)
-
Psoriasis: Epidemiology, Potential Triggers, Disease Course
Pages 27-37
Grozdev, Ivan (et al.)
-
Topical Therapy I: Corticosteroids and Vitamin D Analogues
Pages 39-49
Yang, Eric J. (et al.)
-
Topical Therapy II: Retinoids, Immunomodulators, and Others
Pages 51-69
Guenther, Lyn C.
-
Topical Therapy II: Retinoids, Immunomuodulators, and Others/Ultraviolet Therapy for Psoriasis
Pages 71-91
Beck, Kristen M. (et al.)
-
Laser Therapy in Psoriasis
Pages 93-101
Thibodeaux, Quinn (et al.)
-
Traditional Systemic Therapy I: Methotrexate and Cyclosporine
Pages 103-118
Boh, Erin (et al.)
-
Traditional Systemic Therapy II: Retinoids and Others
Pages 119-140
Ramachandran, Vignesh (et al.)
-
Apremilast
Pages 141-144
Bagel, Jerry (et al.)
-
Etanercept
Pages 145-151
Alexis, Andrew F. (et al.)
-
Adalimumab for Psoriasis
Pages 153-172
Tye, Cooper B. (et al.)
-
Infliximab, Golimumab, and Certolizumab Pegol
Pages 173-199
Mojeski, Jacob A. (et al.)
-
Ustekinumab
Pages 201-212
Han, George (et al.)
-
Guselkumab
Pages 213-224
Joshipura, Deep (et al.)
-
Tidrakizumab
Pages 225-233
Han, George
-
Risankizumab
Pages 235-241
Lee, Erica B. (et al.)
-
Secukinumab for the Treatment of Inflammatory Skin and Joint Disease
Pages 243-251
Hawkes, Jason E. (et al.)
-
Ixekizumab
Pages 253-262
Ryan, Caitriona (et al.)
-
Brodalumab
Pages 263-278
Silfvast-Kaiser, Annika S. (et al.)
-
Biosimilars for Psoriasis
Pages 279-289
Lonowski, Sarah (et al.)
-
Research Pipeline I: Oral Therapeutics for Psoriasis
Pages 291-302
Grand, D. (et al.)
-
Research Pipeline II: Upcoming Biologic Therapies
Pages 303-310
Cices, Ahuva D. (et al.)
-
Pediatric Psoriasis
Pages 311-342
Tolliver, Starling (et al.)
-
Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement
Pages 343-362
Crowley, Jeffrey J.
-
Psoriasis and Comorbidities
Pages 363-397
Laws, Philip M. (et al.)
-
Summary of Published Treatment Guidelines
Pages 399-414
Ramachandran, Vignesh (et al.)
